Sparx Therapeutics
Business Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
700 E Business Center Dr, Mount Prospect...Phone Number
(959) 603-6035Website
www.sparxbio.comRevenue
<$5 MillionIndustry
About Sparx Therapeutics
SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company focused on enhancing human immunity through innovative antibody therapies, particularly in the field of immuno-oncology. The company specializes in the discovery and development of next-generation antibody-drug conjugates (ADCs) and multi-specific antibodies. Their integrated capabilities include biologics production, process development, and optimization, aimed at addressing the challenges in drug development. SparX targets clients in the healthcare sector, particularly those involved in cancer treatment and immunotherapy.Explore more
Sparx Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sparx Therapeutics
Compare insights from companies similar to Sparx Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sparx Therapeutics Tech Stack
A closer look at the technologies used by Sparx Therapeutics
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sparx Therapeutics
Sign Up For FreeTo access detailed company insights
SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company focused on enhancing human immunity through innovative antibody therapies, particularly in the field of immuno-oncology. The company specializes in the discovery and development of next-generation antibody-drug conjugates (ADCs) and multi-specific antibodi... Read More
